230 related articles for article (PubMed ID: 25774822)
1. [Effectiveness of low-intensity extracorporeal shock wave therapy on patients with Erectile Dysfunction (ED) who have failed to respond to PDE5i therapy. A pilot study].
Bechara A; Casabé A; De Bonis W; Nazar J
Arch Esp Urol; 2015 Mar; 68(2):152-60. PubMed ID: 25774822
[TBL] [Abstract][Full Text] [Related]
2. Low-intensity extracorporeal shock wave therapy--a novel effective treatment for erectile dysfunction in severe ED patients who respond poorly to PDE5 inhibitor therapy.
Gruenwald I; Appel B; Vardi Y
J Sex Med; 2012 Jan; 9(1):259-64. PubMed ID: 22008059
[TBL] [Abstract][Full Text] [Related]
3. Penile Low Intensity Shock Wave Treatment is Able to Shift PDE5i Nonresponders to Responders: A Double-Blind, Sham Controlled Study.
Kitrey ND; Gruenwald I; Appel B; Shechter A; Massarwa O; Vardi Y
J Urol; 2016 May; 195(5):1550-1555. PubMed ID: 26694904
[TBL] [Abstract][Full Text] [Related]
4. Penile low intensity shock wave treatment for PDE5I refractory erectile dysfunction: a randomized double-blind sham-controlled clinical trial.
Vinay J; Moreno D; Rajmil O; Ruiz-Castañe E; Sanchez-Curbelo J
World J Urol; 2021 Jun; 39(6):2217-2222. PubMed ID: 32696128
[TBL] [Abstract][Full Text] [Related]
5. Twelve-Month Efficacy and Safety of Low-Intensity Shockwave Therapy for Erectile Dysfunction in Patients Who Do Not Respond to Phosphodiesterase Type 5 Inhibitors.
Bechara A; Casabé A; De Bonis W; Ciciclia PG
Sex Med; 2016 Dec; 4(4):e225-e232. PubMed ID: 27444215
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of clinical efficacy, safety and patient satisfaction rate after low-intensity extracorporeal shockwave therapy for the treatment of male erectile dysfunction: an Australian first open-label single-arm prospective clinical trial.
Chung E; Cartmill R
BJU Int; 2015 Apr; 115 Suppl 5():46-9. PubMed ID: 25828173
[TBL] [Abstract][Full Text] [Related]
7. Low intensity extracorporeal shockwave therapy for erectile dysfunction: a study in an Indian population.
Srini VS; Reddy RK; Shultz T; Denes B
Can J Urol; 2015 Feb; 22(1):7614-22. PubMed ID: 25694008
[TBL] [Abstract][Full Text] [Related]
8. The Role of the Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Radical Prostatectomy: A Randomized Clinical Trial.
Baccaglini W; Pazeto CL; Corrêa Barros EA; Timóteo F; Monteiro L; Saad Rached RY; Navas A; Glina S
J Sex Med; 2020 Apr; 17(4):688-694. PubMed ID: 32007430
[TBL] [Abstract][Full Text] [Related]
9. Does low intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short-term results of a randomized, double-blind, sham controlled study.
Vardi Y; Appel B; Kilchevsky A; Gruenwald I
J Urol; 2012 May; 187(5):1769-75. PubMed ID: 22425129
[TBL] [Abstract][Full Text] [Related]
10. Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction in Diabetic Patients.
Spivak L; Shultz T; Appel B; Verze P; Yagudaev D; Vinarov A
Sex Med Rev; 2021 Oct; 9(4):619-627. PubMed ID: 31378506
[TBL] [Abstract][Full Text] [Related]
11. Low intensity shockwave therapy in combination with phosphodiesterase-5 inhibitors is an effective and safe treatment option in patients with vasculogenic ED who are PDE5i non-responders: a multicenter single-arm clinical trial.
Palmieri A; Arcaniolo D; Palumbo F; Verze P; Liguori G; Mondaini N; Falcone M; Scroppo FI; Salonia A; Cai T;
Int J Impot Res; 2021 Sep; 33(6):634-640. PubMed ID: 32683417
[TBL] [Abstract][Full Text] [Related]
12. Low-intensity shock wave therapy ameliorates erectile dysfunction in men with pelvic fractures associated with urethral injury.
Wang CJ; Lu YM; Li CC; Wu WJ; Chien TM
Int J Impot Res; 2019 May; 31(3):218-222. PubMed ID: 30420772
[TBL] [Abstract][Full Text] [Related]
13. Impact of aging and comorbidity on the efficacy of low-intensity shock wave therapy for erectile dysfunction.
Hisasue S; China T; Horiuchi A; Kimura M; Saito K; Isotani S; Ide H; Muto S; Yamaguchi R; Horie S
Int J Urol; 2016 Jan; 23(1):80-4. PubMed ID: 26501992
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of low-intensity shockwave therapy plus tadalafil 5 mg once daily in men with type 2 diabetes mellitus and erectile dysfunction: a matched-pair comparison study.
Verze P; Capece M; Creta M; La Rocca R; Persico F; Spirito L; Cardi A; Mirone V
Asian J Androl; 2020; 22(4):379-382. PubMed ID: 31696836
[TBL] [Abstract][Full Text] [Related]
15. Low-Intensity Extracorporeal Shockwave Therapy Can Improve Erectile Function in Patients Who Failed to Respond to Phosphodiesterase Type 5 Inhibitors.
Tsai CC; Wang CJ; Lee YC; Kuo YT; Lin HH; Li CC; Wu WJ; Liu CC
Am J Mens Health; 2017 Nov; 11(6):1781-1790. PubMed ID: 28884638
[TBL] [Abstract][Full Text] [Related]
16. Combination of vacuum erection device and PDE5 inhibitors as salvage therapy in PDE5 inhibitor nonresponders with erectile dysfunction.
Canguven O; Bailen J; Fredriksson W; Bock D; Burnett AL
J Sex Med; 2009 Sep; 6(9):2561-7. PubMed ID: 19627462
[TBL] [Abstract][Full Text] [Related]
17. Long-term effectiveness and predictors of success of low-intensity shockwave therapy in phosphodiesterase type 5 inhibitors non-responders.
Musa ZS; El-Assmy A; Shokry AM; Shokeir AA; Zween T; Al-Kenawy MR
Arab J Urol; 2020; 18(1):54-58. PubMed ID: 32082635
[No Abstract] [Full Text] [Related]
18. Safety and efficacy of intraurethral alprostadil in patients with erectile dysfunction refractory to treatment using phosphodiesterase-5 inhibitors.
Garrido Abad P; Sinués Ojas B; Martínez Blázquez L; Conde Caturla P; Fernández Arjona M
Actas Urol Esp; 2015 Dec; 39(10):635-40. PubMed ID: 26049734
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal shockwave therapy in the treatment of erectile dysfunction: a prospective, randomized, double-blinded, placebo controlled study.
Yee CH; Chan ES; Hou SS; Ng CF
Int J Urol; 2014 Oct; 21(10):1041-5. PubMed ID: 24942563
[TBL] [Abstract][Full Text] [Related]
20. A 6-month, prospective, observational study of PDE5 inhibitor treatment persistence and adherence in Middle Eastern and North African men with erectile dysfunction.
El-Meliegy A; Rabah D; Al-Mitwalli K; Mostafa T; Hussein T; Istarabadi M; Lei Y; Gurbuz S
Curr Med Res Opin; 2013 Jun; 29(6):707-17. PubMed ID: 23540436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
